dizzy on tirzepatide Spells and Tirzepatide: Can This Weight Loss Drug Be the Cause? The Risk of Vestibular Disorders

[DOI] [PubMed] [Google Scholar] 16.GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art

So that speaks to this whole idea that there's a biological set point

Noura Abul-Husn, Chief Medical Officer of the 23andMe Research Institute, who views the data as a catalyst for better patient-doctor relationships: For healthcare professionals, the true value of this data lies in its potential to transform weight loss discussions from a trial-and-error approach into data-driven, shared decision-making with patients

The additional weight in the abdomen puts pressure on the bladder and the legs, which may result in some fluid retention in the lower limbs, ankles, and feet

By overcoming physiological weight loss hurdles, Zepbound makes sustaining a calorie deficit manageable without persistent hunger, which is vital for those who face challenges losing weight

Keeping a food diary can help you monitor your progress